GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort
about
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesIntegrative Analysis of Proteomic, Glycomic, and Metabolomic Data for Biomarker Discovery.Topic model-based mass spectrometric data analysis in cancer biomarker discovery studiesBCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal CancerRevealing Potential Biomarkers of Functional Dyspepsia by Combining 1H NMR Metabonomics Techniques and an Integrative Multi-objective Optimization Method.Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics.Applications of Metabolomics in Cancer Studies.An analysis of the types of recently published research in the field of cachexia.Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma.Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
P2860
Q26741550-6240687D-2AF5-49A7-B2DF-95B5154A25F6Q31104649-50AD9CF1-9ACB-4D02-AF26-67FD8D944519Q31122171-E1168825-7582-46D0-AF50-D124D608FAF9Q33817695-52581756-4105-4C36-A8F6-6DEF797418F1Q36442812-7303AB2C-CF14-4C47-8F5C-27217E65E9ABQ37421650-AD5B07CA-BFCE-4BC1-BFD2-842903F7B18CQ38993393-E25C6821-145B-4FC0-B83E-409AF80730CEQ39450826-9E9D210A-9C18-4FE8-AFE0-BAB69B285C7CQ40354565-8582BA55-D11F-4CA4-845A-9B76FA095295Q47568983-6DE8DB4E-E5AB-40D5-A2B7-3C41E71E5847Q49717949-5AC9AC6A-1A08-4909-BA87-9D216D728D3EQ49787544-9B5FA03E-C68F-4728-92D5-B1C508CD8E9FQ50540296-4FABD7A5-08A1-42F6-8413-26137222278EQ52564715-08A7B695-0E40-4B90-9E7E-AB871DE086FDQ54256088-0D7920B6-F6CD-4449-858D-417E4BC957BC
P2860
GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@ast
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@en
type
label
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@ast
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@en
prefLabel
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@ast
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@en
P2093
P2860
P1433
P1476
GC-MS Based Plasma Metabolomic ...... r Carcinoma in Egyptian Cohort
@en
P2093
Cristina Di Poto
Dina H Ziada
Habtom W Ressom
Hanan Soliman
Mahlet G Tadesse
Mohammad R Nezami Ranjbar
Naglaa I Sarhan
Rabindra Roy
Rency S Varghese
P2860
P304
P356
10.1371/JOURNAL.PONE.0127299
P407
P577
2015-06-01T00:00:00Z